NEWS
Tags: 

Partnership in cancer fight

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and GenoSplice Technology, developers of bioinformatics solutions for analysis of genomic data, have formed a partnership.

The collaboration will provide GenoSplice with access to several Curie-Cancer technology platforms to allow it to continue to improve its services to its clients. GenoSplice will, in turn, be included in Institut Curie research programmes and will benefit from access to the intellectual property generated during the projects.

This agreement will allow GenoSplice to specifically contribute to the development of new products against cancer. The agreement also facilitates better understanding of complex diseases such as cancer through genome mapping.

GenoSplice will use Curie-Cancer’s genomic platform to continue to offer data processing to their primary client base – large pharmaceutical laboratories, biotechnology companies and academic research centres.

The clients use GenoSplice to process the data gathered from high-speed sequencing and/or DNA microarrays, as well as to obtain a better understanding of the biological mechanisms involved with alternative splicing for their R&D projects.

'Participating in research projects with the Institut Curie, which are sometimes multi-party and involve other international research institutes, will put us at the forefront of developments in our areas of interest and will enable us to provide the best possible service to our clients,' said Pierre de la Grange, scientific director and co-founder of GenoSplice.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Gemma Church finds out how astronomers are using simulations to investigate the extremities of our universe

Feature

Turning data into scientific insight is not a straightforward matter, writes Sophia Ktori

Feature

The Leibniz Supercomputing Centre (LRZ) is driving the development of new energy-efficient practices for HPC, as Robert Roe discovers

Feature

William Payne investigates the growing trend of using modular HPC, built on industry standard hardware and software, to support users across a range of both existing and emerging application areas

Feature

Robert Roe looks at developments in crash testing simulation – including larger, more intricate simulations, the use of optimisation software, and the development of new methodologies through collaboration between ISVs, commercial companies, and research organisations